Most Read Articles
6 days ago
Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.
4 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 5 days ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 2 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.

Older age, arrhythmia predict impaired processing speed in stroke survivors

11 Feb 2019

Impaired processing speed (IPS) in stroke survivors may persist long after the index event, a study reports. Some of the baseline factors that predict IPS include older age, arrhythmia, previous stroke and coronary artery disease.

Researchers assessed IPS using the Symbol Digit Modalities Test (SDMT) 4 years after stroke in a cohort of 133 survivors (mean age 67.0 years). Baseline factors potentially associated with IPS were determined at time of stroke and/or within 2 weeks of the acute event.

Long-term IPS was highly prevalent, with 62 percent of survivors having a mean SDMT score <40 at 4 years after stroke.

Multivariable regression models revealed the following baseline variables as significant predictors of long-term IPS: arrhythmia (odds ratio [OR], 4.40; 95 percent CI, 1.5–12.4; p=0.01), coronary artery disease (OR, 3.35; 1.6–9.6; p=0.01), older age (OR, 3.03; 0.9–9.3; p=0.05), previous stroke (OR, 2.74; 1.0–7.4; p=0.05), cholesterol (OR, 2.72; 1.3–5.4; p=0.01) and hypertension (OR, 1.82; 0.9–3.6; p=0.05).

Findings of the present study may aid in identification of stroke patients who are at higher risk of IPS, researchers said. Early identification is especially important to target rehabilitation interventions and improve overall outcomes.

IPS affects up to 70 percent of stroke survivors and exerts a huge influence on poststroke cognitive dysfunction, leading to a poor quality of life and increased dependence on others, they added.

Editor's Recommendations
Most Read Articles
6 days ago
Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.
4 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 5 days ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 2 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.